They were operating under a simple rule:
If something is wrong, I will feel it.
Led messaging and content strategy across acquisition, campaign experience, and conversion pathways.
Defined and enforced the core narrative that replaced the default conclusion suppressing screening behavior.
Aligned marketing, campaign, and lifecycle teams around a single lens so users encountered the same meaning at every touchpoint.
Set and governed the standard for how messaging was
executed across the system.
Patients believed feeling fine meant they were not at cardiovascular risk.
That assumption killed consideration early. Screening wasn’t
rejected, it was never seriously considered.
Reframed symptom absence from reassurance to uncertainty, redefining risk as something that must be measured rather than felt.
Repositioned risk from something users feel to something that must be measured.
That shift made screening relevant and necessary.
Once symptom absence was seen as uncertainty instead of reassurance, behavior changed. Measurable increases in screening followed.
The campaign targeted men aged 40 to 65 with elevated cardiovascular risk and low routine healthcare engagement.
The offer was a free 15-minute screening measuring blood pressure and cholesterol.
People entered the funnel aware of general health risk and still chose not to act.
Traffic quality was strong.
Participation remained low.
Conversion wasn’t constrained by awareness, access, or offer quality.
Those variables were already working.
The constraint was the rule prospects used to evaluate their health:
If nothing feels wrong, there is no risk.
That rule dictated everything that followed. It determined how symptoms were interpreted, how risk information was evaluated, and whether screening was ever considered.
It created a closed loop:
If no symptoms → no problem
If no problem → no need to act
Through that lens, screening never enters consideration. It isn’t compared, weighed, or evaluated. It’s dismissed immediately.
Additional information reinforced the same conclusion from a different angle.
This was the constraint the strategy had to remove.
Patients adjusted their behavior around that rule:
Screening didn’t feel necessary.
Risk didn’t feel immediate.
The constraint wasn’t awareness.
It was how prospects determined whether they were at risk.
As long as risk was evaluated through how they felt, no amount of information would change behavior.
The leverage point became changing how risk is determined.
I made a deliberate decision not to add more information, but to replace the rule patients were using to determine risk.
Risk was reframed as something that cannot be felt and must be measured.
From:
If I feel fine, I’m safe
To:
Current risk can only be determined through measurable indicators such as
blood pressure and cholesterol
A new model replaced the old one:
Symptom absence does not confirm safety. It creates
uncertainty that must be resolved through measurement.
Defined and enforced a single governing idea across all messaging in the funnel:
Risk is determined through measurement, not how someone feels.
Three principles held the system together:
One explanation carried across all messaging
The model was established before introducing screening
Message consistency reinforced across every touchpoint
Content followed a fixed sequence:
Start with what prospects already trust
→ feeling fine
Break the assumption
→ feeling fine cannot confirm safety
Then expand the implication
→ risk exists independently of symptoms
Only then introduce screening
→ the only way to verify current status
This replaced the patients underlying logic entirely.
The same logic was reinforced from first interaction through decision.
Directed and controlled messaging across the full journey so each stage reinforced the same decision logic.
At awareness, prospects saw that feeling fine does not reflect cardiovascular status.
At consideration, measurable indicators were established as the way to determine risk.
At decision, screening became the method to verify status.
In follow-up, the same model reinforced continued engagement.
At every stage, patients evaluated their condition through measurement, not perception.
These gains came from changing the decision logic,
not increasing spend or adjusting the offer.
Performance improved once prospects stopped using how they felt to determine risk.
When risk required measurement, screening became relevant.
Patients moved through a clear sequence:
I identify the conclusion driving inaction, replace it with a governing idea, and enforce it across the system so it drives decision-making.
Patients don’t ignore solutions randomly. They decide early that it doesn’t apply.
That decision is the lever.
Change that and buyer action follows.
Let’s fix what’s actually suppressing performance →